HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Roche develops PCR test for Bundibugyo virus in six days

Created at 4 Jun · 6:28 AM2 sources↑ Market-relevant2 events
IN SHORT

Roche has rapidly developed a PCR test for the Bundibugyo virus within six days of the genome sequence being published. This assay aims to support efforts to address the urgent need for detection during ongoing outbreaks.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

six daysdevelopment time for PCR test

Who's Involved

Roche
Developed a rapid PCR test for Bundibugyo virus

↳ Why This Matters

The rapid development of diagnostic tests for emerging viral threats like the Bundibugyo virus is crucial for timely intervention and containment during outbreaks, potentially saving lives and mitigating public health crises.

Key facts

  • Roche developed a PCR test for the Bundibugyo virus.
  • The test was developed within six days of the genome sequence publication.
  • The test targets detection of the Bundibugyo virus.

Roche has rapidly developed a PCR test for the Bundibugyo virus, completing the assay within six days of the genome sequence being published. This development is intended to support efforts to address the critical need for detection during ongoing outbreaks. Roche's capabilities in responding to outbreaks enabled this swift development.

Frequently asked questions

The new Roche test targets the Bundibugyo virus.

The test was developed within six days of the Bundibugyo virus genome sequence being published.

Roche's unique outbreak response capabilities enable the rapid development of diagnostic tests.

What Happens Next

01The test will support efforts to address the critical need for detection during ongoing outbreaks.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

4 Jun · 3:33 PM
Roche developed a PCR test for Bundibugyo virus in six days, addressing an urgent need for detection during outbreaks.
PRN | All News Releases via PiQSuite
3 Jun · 12:12 PM
VolitionRx has filed a new patent for its Nu.Q® NETs test, aiming to aid in Ebola triage and treatment monitoring.
PRN | All News Releases via PiQSuite

Sources

T1
VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoringm.piqsuite.com
T1
Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detectionm.piqsuite.com

Related Stories

City Labs launches world's first commercial nuclear-powered satellite
8 Jul · 5:30 PM
OpenAI launches GPT-Live voice models for simultaneous listening and speaking
8 Jul · 5:56 PM
BofA extends $520 million credit line to OpenAI ahead of IPO
8 Jul · 4:59 PM
Manna launches US drone delivery operations in Tulsa
8 Jul · 7:00 PM
Venus Aerospace raises $90M Series B for rocket engine development
8 Jul · 2:30 PM